Consider pregnancy in COVID-19 therapeutic drug and vaccine trials

Lancet. 2020 May 23;395(10237):e92. doi: 10.1016/S0140-6736(20)31029-1. Epub 2020 May 13.

Authors

Clare L Whitehead¹, Susan P Walker²

Affiliations

¹ Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC 3052, Australia; Pregnancy Research Centre, The Royal Women's Hospital, Parkville, VIC, Australia. Electronic address: clarew@unimelb.edu.au.
² Department of Obstetrics and Gynaecology, University of Melbourne, Parkville, VIC 3052, Australia; Mercy Perinatal, Mercy Hospital for Women, Heidelberg, VIC, Australia.

No abstract available

Publication types

Letter

MeSH terms

Betacoronavirus
COVID-19
COVID-19 Vaccines
Clinical Trials as Topic*
Coronavirus Infections / drug therapy*
Coronavirus Infections / prevention & control*
Female
Humans
Pandemics / prevention & control*
Patient Selection*
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / prevention & control*
Pregnancy
Pregnant People*
SARS-CoV-2
Viral Vaccines

Substances

COVID-19 Vaccines
Viral Vaccines